
U.S. regulators are requiring the makers of blockbuster drugs like Ozempic and Zepbound to include warnings about a rare eye condition that can cause permanent vision loss
来源:WSJ发布于 2026-11-09
The FDA is requiring the makers of drugs like Ozempic and Zepbound to include warnings about a rare eye condition that can cause permanent vision loss.
本文内容来自外部来源,点击「继续访问」将跳转到原始发布站点。